In February 2023, the Foundation signed an MoU (Memorandum of understanding) with Oslo Science City and Copenhagen Science City. This gives us the opportunity for deeper collaboration and knowledge exchange.
An innovation hub for biological production to enable the verification of biological, technical, and digital innovations in an authentic production environment. Testa Center is a joint venture between the Swedish government and Cytiva to promote growth in life science.
Applying artificial intelligence, machine learning, and blockchain in life science is becoming increasingly common.
With pride and joy, we announce that Cecilia Schelin Seidegård, chairman of the board at Stockholm Science City, has been awarded the medal "For outstanding contributions to society" by the King.
A new biobank act comes into force on July 1, 2023. Mark Divers is the director of KI Biobank, for pre-analytical handling, storage, and distribution of human biological samples for research at Karolinska Institutet. Here he explains why a biobank law is needed, what changes the new act brings, and how it strengthens Sweden as a life science nation.
Biobanks are essential for good and equal care, clinical research, and Sweden's competitiveness in Life Science. With the help of biobank samples, it is possible to prevent or alleviate the effects of public diseases, epidemics, and pandemics, which we clearly experienced during covid-19. Collaboration between all stakeholders in Life Science is key.
Data has always been a foundation for research, innovation, and the development of health care. Access to data generated in healthcare for secondary use – i.e. for purposes such as research, product development, or community planning – is limited and it is often claimed that health data is underutilized.